Journal of Cardiovascular Pharmacology

APRIL 8, 2024

Multiple studies have shown that long non-coding RNAs (lncRNAs) play a significant role in the progression of cardiovascular and cerebrovascular diseases. Multiple studies have shown that long non-coding RNAs (lncRNAs) play a significant role in the progression of cardiovascular and cerebrovascular diseases.

Aneurysm 40

Aneurysm Cerebrovascular Disease Biomarkers Article 40

HeartRhythm

APRIL 30, 2024

However, the data on neurological outcomes including cerebrovascular disease (CVA) and dementia remain a controversy. Catheter ablation (CA) of atrial fibrillation (AF) has been proved to benefit patient with symptomatic AF and heart failure.

Atrial Fibrillation 40

Atrial Fibrillation Cerebrovascular Disease Ablation Dementia 40

Frontiers in Cardiovascular Medicine

JUNE 26, 2024

Hypertension is a significant risk factor for cardiovascular and cerebrovascular diseases and has become a global public health concern. Although hypertension results from a combination of factors, the specific mechanism is still unclear.

Hypertension 52

Hypertension Cerebrovascular Disease Public Health Transplant 52

Cardiovascular Diabetology

AUGUST 27, 2024

Our subgroup analysis revealed that mothers with a history of GDM faced various risks (20% to 2-fold) of developing different subtypes of CVDs, including cerebrovascular disease, coronary artery disease, heart failure, and venous thromboembolism.

Cardiovascular Disease 85

Cardiovascular Disease Diabetes Cerebrovascular Disease Coronary Artery Disease 85

Open Heart

NOVEMBER 9, 2024

Patients with IONM were more likely to have had baseline cerebrovascular disease (60% vs 22%). Propensity-score matching was employed to assess the association of IONM usage with operative mortality and stroke. Results A total of 19 299 patients underwent a cardiac operation, of which 589 (3.1%) had IONM. vs 2.5%) and stroke (4.9%

Cerebrovascular Disease 52

Cerebrovascular Disease Strokes Stroke Biomarkers 52

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Results Brandenburg patients with cardiovascular diseases showed higher Lp(a) levels than healthy controls (24.2% vs. 14.8%, p  = 0.001), and the high-Lp(a) group demonstrated a higher prevalence of coronary artery disease, peripheral artery disease, or cerebrovascular disease than the low-Lp(a) group ( p  = 0.004).

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease 59

Stroke Journal

FEBRUARY 1, 2024

ICD10 Codes I60-I69 were used to indicate cerebrovascular disease. CTA Head, CTP, MRI Brain, and Non-contrast CT Head imaging use was determined from Common Procedural Terminology (CPT) codes. Detailed diagnosis and hospital demographic data to be presented.

Cerebrovascular Disease 40

Cerebrovascular Disease Hospital Strokes Stroke 40

Stroke Journal

JANUARY 18, 2024

Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias. Stroke, Ahead of Print.

Dementia 90

Dementia Cerebrovascular Disease Biomarkers Strokes 90

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Methods This narrative review examines the contemporary literature assessing intermediate- and long-term event rates in patients with established CV disease treated with statins. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease 64

DAIC

JULY 29, 2024

Early identification allows for timely initiation of guideline-directed medical therapy for secondary prevention of cardiovascular disease, cerebrovascular disease, and limb events.

Certification 108

Certification Peripheral Arterial Disease Cerebrovascular Disease Quality of Life 108

Hypertension Journal

MARCH 28, 2024

BP, a heritable quantitative trait affected by numerous biological and environmental stimuli, is a major cause of morbidity and mortality worldwide and is considered to be a primary modifiable factor in renal, cardiovascular, and cerebrovascular diseases.

Blood Pressure 40

Blood Pressure Cerebrovascular Disease Hypertension 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Lipoprotein(a) [Lp(a)] is a known risk factor for cardiovascular disease; however, its association with cerebrovascular disease is not as well established.Methods:Data from HCHS/SOL, a population-based cohort of Hispanics/Latinos, was utilized.

Cerebrovascular Disease 40

Cerebrovascular Disease Strokes Stroke Risk Factors 40

Hypertension Journal

JANUARY 2, 2024

Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide. Hypertension, Ahead of Print.

Hypertension 40

Hypertension Blood Pressure Cerebrovascular Disease Risk Factors 40

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2024

By comparing myocardial injury patients with non-myocardial injury patients, notable differences were observed in age, pre-existing medical conditions (e.g.,

Risk Factors 64

Risk Factors Laboratory Cerebrovascular Disease Coronary Artery Disease 64

Frontiers in Cardiovascular Medicine

JANUARY 21, 2024

Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL).

Cardiovascular Disease 45

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Coronary Artery Disease 45

DAIC

FEBRUARY 9, 2024

The data were presented yesterday at the 2024 International Stroke Conference (AZ), a premier event featuring global thought leaders and dedicated to the latest in the science and treatment of cerebrovascular disease and brain health. A total of 17 sites and 123 patients participated across the United States and France.

Strokes 105

Strokes Stroke Cerebrovascular Disease Technology 105

Stroke Journal

FEBRUARY 1, 2024

Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024.

Stenosis 40

Stenosis Sickle Cell Disease Cerebrovascular Disease Pediatrics 40

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundBrain arterial diameters (BADs) are novel imaging biomarkers of cerebrovascular disease, cognitive decline, and dementia. Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023.

Cerebrovascular Disease 40

Cerebrovascular Disease Dementia Biomarkers Risk Factors 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionStroke is the most common manifestation of cerebrovascular disease, which requires prompt diagnosis and treatment. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.

Cerebrovascular Disease 40

Cerebrovascular Disease Dementia Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis. Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024.

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Circulation Strokes 40

Stroke Journal

FEBRUARY 1, 2024

These variants included mutations in MYLK, COL5A1, COL5A2, KRIT1, CCM2, XPR1, MT-CYB, MT-ND4, and MT-ATP6 genes.This study highlights that in the right clinical population, like young patients with recurrent stroke, genetic testing can be helpful to elucidate the etiology of cerebrovascular disease when standard stroke work up is inconclusive.

Strokes 40

Strokes Stroke Cerebrovascular Disease Outpatient 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Despite significant efforts to increase public awareness of cerebrovascular disease, the incidence of stroke and transient ischemic attack (TIA) in young adults has remained elevated, representing a major public health concern. Stroke, Volume 55, Issue Suppl_1 , Page ATP271-ATP271, February 1, 2024.

Strokes 40

Strokes Stroke Cerebrovascular Disease Risk Factors 40

Stroke Journal

FEBRUARY 1, 2024

In patients with preexisting cerebrovascular disease, pollution exposure can compound underlying pathology and may accelerate functional decline. Stroke, Volume 55, Issue Suppl_1 , Page A18-A18, February 1, 2024. Background:Exposure to ambient air pollution causes neuroinflammation and white matter (WM) damage.

Cerebrovascular Disease 40

Cerebrovascular Disease Stenosis Strokes Stroke 40

Stroke Journal

OCTOBER 10, 2023

BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023.

Kidney Disease 40

Kidney Disease Strokes Stroke Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:Moyamoya disease (MMD) is a rare cerebrovascular disease that can lead to stroke. Stroke, Volume 55, Issue Suppl_1 , Page AWMP118-AWMP118, February 1, 2024.

Cerebrovascular Disease 40

Cerebrovascular Disease Strokes Stroke 40

Stroke Journal

FEBRUARY 1, 2024

This new modality using a physical parameter could lead to the development of innovative therapies to prevent and treat a wide array of cerebrovascular diseases. NIR-II photobiomodulation offers a non-invasive and low-risk treatment for stroke.

Strokes 40

Strokes Stroke Cerebrovascular Disease Innovation 40

All About Cardiovascular System and Disorders

MARCH 23, 2024

Relative contraindications for HUTT include: Severe left ventricular outflow obstruction Critical mitral stenosis Severe proximal coronary artery disease Severe cerebrovascular disease

Blood Pressure 52

Blood Pressure Bradycardia POTS Tachycardia 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionInterventional Neurology (IN) is a rapidly expanding field, with new devices and techniques broadening the range of cerebrovascular diseases that can be treated (1). Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Education Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

ConclusionLimb‐shaking TIA is an important yet underrecognized manifestation of relative cerebral hypoperfusion related to severe cerebrovascular disease. This case describes bilateral limb shaking episodes in a patient with severe bilateral carotid disease ‐ a rare manifestation of limb‐shaking TIA.

Stenosis 40

Stenosis Cerebrovascular Disease Diabetes Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, occult cerebral amyloid angiopathy can also present similarly, and their management is markedly different.MethodsWe present a case of recurrent bilateral medial frontal hemorrhage in a patient without known cerebrovascular disease that evaded diagnosis despite hematologic evaluation, MRI, CTA, two DSAs, three clot evacuations with pathology, (..)

Hemorrhage 40

Hemorrhage AFIB Cerebrovascular Disease Thrombosis 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

He had a documented history of transient‐ischemic attack and was noted to have undergone progressive cognitive decline.

Arterioles 40

Arterioles Cerebrovascular Disease Outpatient Document 40

DAIC

FEBRUARY 8, 2024

In the future, we hope to have more AI applications validated through clinical research and hope that the clinical decision support system can be expanded to include more aspects of stroke care, including reperfusion therapy and long-term secondary prevention, rehabilitation and so on.

Strokes 105

Strokes Stroke Research Heart attacks 105

Stroke Journal

FEBRUARY 1, 2024

Introduction:Blunted night-to-day blood pressure (BP) dipping was common in ischemic cerebrovascular disease (ICVD). Stroke, Volume 55, Issue Suppl_1 , Page AWP289-AWP289, February 1, 2024. BP dipping could be influenced by baroreflex, which stabilized BP by regulating sympathovagal balance.

Blood Pressure 40

Blood Pressure Cerebrovascular Disease Risk Factors Strokes 40

Heart BMJ

FEBRUARY 12, 2024

Four major cardiovascular admission events were identified during the follow-up: chronic ischaemic heart disease (CIHD), cerebrovascular disease, atrial fibrillation and heart failure. Methods A total of 285 009 participants free of CVD at baseline from the UK Biobank were included in this analysis.

Cardiovascular Disease 52

Cardiovascular Disease Cerebrovascular Disease Atrial Fibrillation Heart Failure 52

Cardiomatics

AUGUST 4, 2022

According to WHO , cardiovascular diseases are the leading cause of death worldwide – it is estimated that they are the cause of 17.9 Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Cerebrovascular Disease 52

Circulation

NOVEMBER 11, 2024

Each subcategory of CVD mortality (ischemic heart disease, hypertension; cerebrovascular disease) showed AAPC increases when stimulants were involved, with hypertensive diseases experiencing the largest AAPC rise at 9.1%.Stratifying decline in overall CVD mortality rates (Table). AAPC, compared to a 3.1%

Cardiovascular Disease 40

Cardiovascular Disease Cerebrovascular Disease Coronary Artery Disease Cardiac Arrest 40

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

Objective Atherosclerosis is a significant cause of cardiovascular and cerebrovascular diseases, with a greater impact on men than women. Dietary antioxidant intake is inversely related to the risk of atherosclerosis development.

Atherosclerosis 69

Atherosclerosis Cerebrovascular Disease Blood Pressure BMI 69